Gold Sponsor
Agilitech
Agilitech is a pioneering partner to the biotech industry. The company helps to drive progress by designing and implementing state-of-the-art equipment and bioprocessing systems for biotech research labs through to full-scale production, along with game-changing bioprocess engineering and automation services.
In a fast-moving industry that is constantly evolving, Agilitech has the flexibility and experience to tailor its offerings to the specific requirements of each and every customer. A transformative product design and engineering process is what makes Agilitech single-use bioprocessing technologies unique and ensures that the company’s solutions meet the exact needs of each and every customer. Through front-end planning and collaborative product design with end users, Agilitech delivers truly fit-for-purpose solutions to real problems.
Associated Experts
Job Title: Biotech Chief Innovation Officer
Associated Content
Agilitech Single-Use Tangential Flow Filtration (TFF) System for Biologics Manufacturing – A Case Study
Manufacturers in the biopharmaceutical industry are facing ever-expanding pipelines and the pressures to increase productivity and long-term sustainability while also rising to meet the challenges of new products with specialized processing requirements. This has led ... Continued
Achieving Peak Flexibility – A single-use filtration skid with multiple application capability
Current expectations for biomanufacturing require downstream systems be responsive and flexible to meet ever changing demands and requirements. A common goal is to create processes that can adapt and evolve over time to meet new ... Continued
Addressing the increasing demand for single-use technologies and supply chain shortages with future proof systems
Phil Sanders talks about the increase in demand for single-use equipment and consumables and how this has led to supply chain shortages....Continued
Future-proof Bioprocesses: Flexible Single-use Technology that Adapts to an Evolving Industry
The one constant in biopharmaceutical manufacturing is change. There is an ever-present need to adapt to new therapeutic modalities, more cost-effective approaches, higher product demands, and now a worldwide pandemic. Thus, the best way to ensure efficient biomanufacturing is to future-proof bioprocesses with flexible systems that enable companies to respond to changing priorities, new opportunities, and increasing demands....Continued
